Why is pregnancy sickness drug not easily accessible to all?

• Dicyclomine (an anti-nausea medication for hyperemesis gravidarum) faces inconsistent NHS availability across regions, creating postcode lottery access to effective treatment for severe pregnancy sickness.
• Supply chain and commissioning issues limit availability despite the drug's clinical efficacy, meaning some pregnant patients cannot access evidence-based pharmacological management.
• Clinicians should be aware of regional variation in access and may need to advocate for patients or explore alternative prescribing pathways when local NHS availability is restricted.

BBC journalist Linzi Kinghorn finds out why a pregnancy sickness drug is not always accessible on the NHS.

ClinicaliQ summarises and contextualises external updates for clinical awareness, then links to the original publisher for the full article and most current context.